128 related articles for article (PubMed ID: 18594942)
1. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.
Tarantino U; Oliva F; Taurisano G; Orlandi A; Pietroni V; Candi E; Melino G; Maffulli N
Amino Acids; 2009 Apr; 36(4):679-84. PubMed ID: 18594942
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific responses to loss of transglutaminase 2.
Deasey S; Shanmugasundaram S; Nurminskaya M
Amino Acids; 2013 Jan; 44(1):179-87. PubMed ID: 22194042
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
[TBL] [Abstract][Full Text] [Related]
4. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.
Johnson KA; Rose DM; Terkeltaub RA
J Cell Sci; 2008 Jul; 121(Pt 13):2256-64. PubMed ID: 18544639
[TBL] [Abstract][Full Text] [Related]
5. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
7. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.
Wang Z; Perez M; Lee ES; Kojima S; Griffin M
Cell Death Dis; 2017 Sep; 8(9):e3032. PubMed ID: 28880274
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
Griffin KJ; Newell LM; Simpson KR; Beckers CML; Drinkhill MJ; Standeven KF; Cheah LT; Iismaa SE; Grant PJ; Jackson CL; Pease RJ
Atherosclerosis; 2020 Feb; 294():1-9. PubMed ID: 31874419
[TBL] [Abstract][Full Text] [Related]
9. Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.
Pitolli C; Pietroni V; Marekov L; Terrinoni A; Yamanishi K; Mazzanti C; Melino G; Candi E
Amino Acids; 2017 Mar; 49(3):635-642. PubMed ID: 27864691
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of plasma transglutaminase factor XIIIA in bone.
Nakano Y; Al-Jallad HF; Mousa A; Kaartinen MT
J Histochem Cytochem; 2007 Jul; 55(7):675-85. PubMed ID: 17341477
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
[TBL] [Abstract][Full Text] [Related]
12. The metastatic tumor antigen 1-transglutaminase-2 pathway is involved in self-limitation of monosodium urate crystal-induced inflammation by upregulating TGF-β1.
Yen JH; Lin LC; Chen MC; Sarang Z; Leong PY; Chang IC; Hsu JD; Chen JH; Hsieh YF; Pallai A; Köröskényi K; Szondy Z; Tsay GJ
Arthritis Res Ther; 2015 Mar; 17(1):65. PubMed ID: 25889736
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminases in mineralized tissues.
Nurminskaya M; Kaartinen MT
Front Biosci; 2006 May; 11():1591-606. PubMed ID: 16368540
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.
Adamczyk M
Amino Acids; 2017 Mar; 49(3):625-633. PubMed ID: 27510997
[TBL] [Abstract][Full Text] [Related]
15. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
Merz D; Liu R; Johnson K; Terkeltaub R
J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
[TBL] [Abstract][Full Text] [Related]
16. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.
Telci D; Collighan RJ; Basaga H; Griffin M
J Biol Chem; 2009 Oct; 284(43):29547-58. PubMed ID: 19657147
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
[TBL] [Abstract][Full Text] [Related]
18. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.
Al-Jallad HF; Myneni VD; Piercy-Kotb SA; Chabot N; Mulani A; Keillor JW; Kaartinen MT
PLoS One; 2011 Jan; 6(1):e15893. PubMed ID: 21283799
[TBL] [Abstract][Full Text] [Related]
19. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
Cecil DL; Terkeltaub R
J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
